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ABSTRACT
The immunological mechanisms involved in the development of duodenal ulcer, especially in
childhood, are unclear. Helicobacter pylori-positive children and adults, with and without duodenal
ulcer, were therefore compared with respect to CD4+ T-cells, and CD8+ T-cells, B-cells and B1a-cells, as
well as cell activation (CD4+ ⁄HLA-DR+ and CD8+ ⁄HLA-DR+) and co-stimulatory (CD4+ ⁄CD28+ and
CD8+ ⁄CD28+) markers, in peripheral blood. Children with and without duodenal ulcer differed
signiﬁcantly. In particular, there was a phenotypic change in CD8+ T-cells from children with ulcer
that involved a 200% increase in the number of CD8+ ⁄HLA-DR+ cells ⁄mm3 and a decrease of 34.2% in
the number of CD8+ ⁄CD28+ cells ⁄mm3. This phenotype of chronically activated memory CD8+ T-cells,
which has also been observed in patients with AIDS and tuberculosis, is associated with disease
severity and progression. A lower frequency of B1a-cells was also observed in the group of children
with ulcer. Conversely, no difference between infected adults with and without ulcer was observed,
but the percentage of CD4+ ⁄HLA-DR+ cells was lower in adults with ulcer, suggesting that a down-
regulated immune response may play a role in the development of duodenal ulcer in adults. Gastric
inﬂammation correlated positively with CD4+ and chronically activated CD4+ T-cells in children and
adults without duodenal ulcer, respectively. These results suggest that there are differences in the
immunophenotyping proﬁle between H. pylori-positive children and adults with duodenal ulcer,
indicating the possibility of distinct immune mechanisms in the development of the disease according
to age.
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INTRODUCTION
The initial isolation and characterisation of
Helicobacter pylori is attributed to Warren and
Marshall [1], who provided evidence that this
organism causes gastritis and peptic ulcer.H. pylori
infects >50% of the world’s population, is
acquired predominantly in childhood, and per-
sists throughout life unless treated [2]. Most
infected individuals remain asymptomatic, but
15–20% of H. pylori-positive individuals will
develop peptic ulcer, gastric carcinoma or muco-
sa-associated lymphoid tissue lymphoma [3].
Although duodenal ulcer (DU) is less common
in children, primary DU in childhood is associ-
ated frequently with H. pylori infection [4,5]. The
reasons for the uncommon early onset of duode-
nal peptic ulcer are unknown, but may be
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associated with an immune response of the host
linked to age [6], rather than with the shorter
duration of the infection in childhood. Indeed,
there are marked differences in the gastric inﬂam-
matory response to H. pylori infection between
children and adults with DU [7]. Although gastric
inﬂammation is less intense in children than in
adults, it is not essentially conﬁned to the antral
region, as occurs in adults, but spreads out
beyond the antrum and involves the gastric
corpus.
Most studies evaluating the immune response
to H. pylori infection have focused on adult
populations [8–10]. Recently, it has been demon-
strated that H. pylori infection in children without
DU, in contrast to adults, does not increase the
number of CD4+ T-cells in the blood, or the
percentage of activation and co-stimulatory T-cell
markers [6]. Since the immune response may
contribute to the outcome of H. pylori infection,
the present study investigated CD4+ T-cells
(CD4+ ⁄CD3+) and CD8+ T-cells (CD8+ ⁄CD3+), B-
cells (CD19+ ⁄CD3–) and B1a-cells (CD19+ ⁄CD5+),
as well as cell activation (CD4+ ⁄HLA-DR+ and
CD8+ ⁄HLA-DR+) and co-stimulatory
(CD4+ ⁄CD28+ and CD8+ ⁄CD28+) markers, in
peripheral blood from H. pylori-infected children
with and without DU, and compared the results
with those obtained from adults. In addition,
lymphocyte phenotypes were correlated with
gastric inﬂammation scores.
PATIENTS AND METHODS
The study was approved by the Ethics Committee of Univer-
sidade Federal de Minas Gerais, Brazil. Signed informed
consent was obtained from the participating adults as well as
from the children (whenever possible) and their parents.
Between January 2000 and July 2001, 25 H. pylori-positive
children (15 boys; mean age 10.2 years, range 4–17 years;
seven children with DU) were studied prospectively. Between
May 2001 and July 2001, 21 H. pylori-positive adults (ﬁve
males, mean age 40.5 years, range 20–73 years, seven with DU)
were also studied. These patients had been examined using
gastroduodeno-endoscopy by the Gastrointestinal Service of
the University Hospital ⁄Universidade Federal de Minas Gerais
and Hospital Felı´cio Rocho, Belo Horizonte, Brazil, to inves-
tigate the origin of symptoms related to the upper gastroin-
testinal tract.
None of the patients had received antimicrobial drugs,
anti-cholinergic or anti-inﬂammatory agents, proton pump
inhibitors, or H2-receptor antagonists for ‡30 days before
endoscopy. Patients who presented with complications,
e.g., gastric perforation or haemorrhage, an anatomical obsta-
cle preventing endoscopy, a history of surgery, bleeding
conditions, or evidence of other clinical symptoms, were not
included in the study. None of the patients was infected by
Trypanosoma cruzi, as demonstrated by negative results in both
a haemagglutination test (Hemacruzi; bioMe´rieux, Rio de
Janeiro, Brazil) and an indirect immunoﬂuorescence test
(IMUNOCOM Chagas; Wama Diagno´stica, Sa˜o Carlos, Brazil).
Intestinal parasitic infections were excluded by using Kato’s,
merthiolate–iodine–formalin and Baermann–Moraes tests to
examine stool samples collected before the endoscopy. The
patients did not have other infectious or immunological
disorders, and all were residents of Minas Gerais state, with
the same ethnic background.
During endoscopy, biopsy specimens were obtained from
the antral and oxyntic gastric mucosa for microbiological
study and histological evaluation. Two venous blood sam-
ples were also obtained from each patient: an EDTA-whole
venous blood for blood cell counting and immunopheno-
typing, and a sample without anticoagulant for the T. cruzi
tests. The serum was separated, divided into aliquots and
stored at )20C before testing. Biopsy samples were ﬁxed in
formalin 10% v ⁄v and parafﬁn-embedded; 5-lm sections
stained with haematoxylin–eosin for histological analysis
were examined by two independent pathologists who were
unaware of their origin. The mucosa were analysed in terms
of the degree of inﬂammation (mononuclear cells) and
activity (neutrophils), with scoring according to the revised
Sydney system [11], i.e., none (0), mild (1), moderate (2) and
marked (3).
H. pylori status was assessed by means of culture, pre-
formed urease test, carbol fuchsin-stained smears and
[13C]urea breath tests [12]. The patients were considered to
be H. pylori-positive if the culture was positive, or if at least
two of the other tests were positive.
Peripheral blood lymphocyte phenotypes were analysed
by immunoﬂuorescence as described previously [6]. The
results were expressed as absolute numbers ⁄mm3 for
CD4+ ⁄CD3+, CD8+ ⁄CD3+ and CD19+ ⁄CD3– cell sets, based
on the total number of peripheral blood lymphocytes, and as
percentages for HLA-DR+- and CD28+-expressing CD4+ and
CD8+ T-cells (CD4+HLA-DR+ ⁄CD4+ cells · 100; CD8+HLA-
DR+ ⁄CD8+ cells · 100; CD4+CD28+ ⁄CD4+ cells · 100; and
CD8+CD28+ ⁄CD8+ cells · 100), and also for CD5+-expressing
CD19+ cells (CD19+CD5+ ⁄CD19+ cells · 100).
The results were analysed using SPSS software v.10.0
(SPSS Inc., Chicago, IL, USA). T- and B-cell absolute
numbers ⁄mm3 of peripheral blood were presented as the
median. Activation and co-stimulatory markers were pre-
sented as a median percentage of CD4+ ⁄CD28+, CD4+ ⁄HLA-
DR+, CD8+ ⁄CD28+, CD8+ ⁄HLA-DR+ and CD19+ ⁄CD5+ cells.
The gastric inﬂammatory data were correlated with the
absolute number ⁄mm3 of T- and B-cells, and with activation
and co-stimulatory T-cell percentages, scored using a three-
point system based on the reference values for each cell
population [6]. This system was as follows: for CD4+ ⁄CD28+:
0, <95%; 1, 95–96%; 2, 97–98%; and 3, >99% of the marked
cells; for CD4+ ⁄HLA-DR+: 0, <5%; 1, 5–10%; 2, 11–15%; and
3, >15% of the marked cells; for CD8+ ⁄CD28+: 0, <25%; 1,
25–50%; 2, 51–80%; and 3, >80% of the marked cells; and
for CD8+ ⁄HLA-DR+: 0, <20%; 1, 20–40%; 2, 41–70%; and 3,
>70% of the marked cells. In order to minimise potential
bias caused by sample size, the data were analysed using
rank tests for small samples. Pearson’s correlation coefﬁcient
(r) was used to evaluate correlations. The level of signiﬁ-
cance was set at p £0.05.
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RESULTS
Children
The gastritis activity (neutrophils) was greater in
the antral mucosa of children with DU than in
those without (p 0.05). No other difference was
observed in the gastric histology of children
(p >0.4) (Table 1). Neither atrophy nor intestinal
metaplasia was seen in the childrens’ gastric
mucosa.
No difference was observed in the number of
CD4+ ⁄CD3+, CD8+ ⁄CD3+ and CD19+ ⁄CD3– cells
between H. pylori-infected children with and
without DU (Fig. S1; see Supplementary mate-
rial). Also, the percentage of CD4+ ⁄CD28+ and
CD4+ ⁄HLA-DR+ cells did not differ between the
two groups. However, a lower percentage of
CD8+ ⁄CD28+ (p 0.05) and a higher percentage of
CD8+ ⁄HLA-DR+ (p 0.04) cells were observed in
children with DU compared to those without.
A lower percentage (p 0.02) of CD19+ ⁄CD5+ cells
was also seen in the former group (Fig. S1). In
order to evaluate the impact of these differences,
the changes in the number of CD8+ ⁄CD28+,
CD8+ ⁄HLA-DR+ and CD19+ ⁄CD5+ cells ⁄mm3
between children with and without DU were
calculated, and the differences remained signif-
icant (p <0.05) (Fig. 1). In the group of children
without DU, the number of CD4+ T-cells was
correlated signiﬁcantly with the intensity (mono-
nuclear cells) (p 0.01; r 0.71) and activity (neu-
trophils) (p 0.004; r 0.71) of the antral gastritis.
A positive correlation was also observed be-
tween the number of B-cells and the intensity of
gastritis in the antral mucosa (p 0.03; r 0.61). No
correlation was observed in the group with DU
(p >0.3).
Adults
No difference was observed between adults with
and without DU in terms of the intensity of the
antral (p 0.6) and oxyntic (p 0.4) gastritis, or in the
activity of the antral (p 0.4) and oxyntic (p 0.3)
gastritis (Table 1). Atrophy was observed in the
antral (n = 3) and oxyntic (n = 2) mucosa of
patients without DU. Intestinal metaplasia in both
gastric mucosa was observed in one patient. No
pre-cancerous lesions were observed in the gastric
mucosa of the group of patients with DU.
The percentage of activated CD4+ T-cells was
signiﬁcantly lower in patients with DU than in
those without (Fig. S1; p 0.03). When the impact
of this difference was evaluated in terms of the
number of activated CD4+ T-cells ⁄mm3, the
results remained signiﬁcant (88 cells ⁄mm3 in
patients without DU; 33 cells ⁄mm3 in patients
with DU; p 0.02). A tendency towards a decrease
in the percentage of CD8+ cells expressing both
CD28+ (p 0.1) and HLA-DR+ (p 0.1) was also
observed in the group with DU, but this did not
reach statistical signiﬁcance. The number of
T- and B-cells, and the percentage of B-cells
expressing CD5, did not differ between infected
adults with and without DU (Fig. S1).
In adults without DU, the degree of inﬂamma-
tion (mononuclear cells) in the antrum correlated
Table 1. Histological comparison of the gastric mucosa of
Helicobacter pylori-positive children and adults with and
without duodenal ulcer (median score according to the
revised Sydney system: 0, none; 1, mild; 2, moderate; 3,
marked)
HP-positive patients
Antral mucosa Oxyntic mucosa
MN cells
(intensity)
PMN cells
(activity)
MN cells
(intensity)
PMN cells
(activity)
With duodenal ulcer
Children 2 (1–3) 2 (1–3) 1 (0–2) 1 (0–1)
Adults 2 (2–3) 2 (2–3) 1 (1–3) 1 (0–3)
Without duodenal ulcer
Children 2 (1–3) 1 (0–3) 1 (0–2) 1 (0–1)
Adults 2 (2–3) 2 (2–3) 2 (1–3) 1 (0–3)
HP, H. pylori; MN, mononuclear; PMN, polymorphonuclear.
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Fig. 1. Changes in the median number of peripheral blood
cells between Helicobacter pylori-positive children with and
without duodenal ulcer. CD8+ ⁄CD28+, range 76–
368 cells ⁄mm3 and 69–940 cells ⁄mm3, respectively; CD8+ ⁄
HLA-DR+, range 77–247 cells ⁄mm3 and 16–532 cells ⁄mm3,
respectively; and CD19+ ⁄CD5+, range 38–200 cells ⁄mm3
and 51–262 cells ⁄mm3, respectively. Statistical treatment:
Mann–Whitney U-test. The grey bar indicates patients with
duodenal ulcer; the white bar indicates patients without
duodenal ulcer.
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positively with the number of CD4+ ⁄HLA-DR+
cells (p 0.05; r 0.87), and negatively with the
number of CD4+ ⁄CD28+ cells (p 0.03; r )0.91).
No other correlation was observed in this group
or the group of patients with DU.
Comparison between children and adults
When children and adults without DU were
compared, the intensity and activity of gastritis,
both in the antral (p 0.006 and p 0.002, respec-
tively) and oxyntic (p 0.005 and p 0.002, respec-
tively) mucosa, were greater in adults than in
children (Table 1). The groups did not differ in
other histological parameters (p >0.2). A higher
number of B-cells (p 0.01) and a higher percent-
age of CD19+ ⁄CD5+ cells (p 0.003) were seen
in children (Fig. S1), but no other differences
between the groups were identiﬁed.
In the group of patients with DU, the intensity
and activity of gastritis did not differ between
adults and children. The number of CD8+ ⁄CD3+
cells (p 0.03) and the percentage of activated
CD4+ (p 0.03) and CD8+ (p 0.01) T-cells were
higher in children than in adults. Furthermore,
the percentage of CD8+ ⁄CD28+ cells was lower in
children than in adults (p 0.05). Otherwise, the
percentage of CD19+ ⁄CD5+ cells did not differ
between children and adults (p 0.7) (Fig. S1).
DISCUSSION
In adults, H. pylori infection increases the number
of CD4+ T-cells and induces activation of both
CD4+ and CD8+ T-cells [6,8–10]. Conversely,
infection in children without DU affects neither
the number of CD4+ and CD8+ T-cells nor
the percentage of activation of the T-cells and
co-stimulatory markers [6]. This more regulated
immune response may explain, at least in part,
why H. pylori infection is not complicated by DU
in most infected children. Since the immune
response may contribute to the outcome of
H. pylori infection, the present study compared
children and adults with and without DU. The
most notable ﬁnding was a phenotypic change in
children with DU that included a three-fold
increase in the number of CD8+ T-cells expressing
the activation marker HLA-DR+, and a decrease
of c. 34% in the number of CD8+ ⁄CD28+ cells.
CD28 is a cell surface molecule that is critically
involved in T-cell co-stimulation, leading to
increased expression of interleukin-2, interleu-
kin-2 receptor and genes for cell survival [13]. At
the time of birth, almost all CD8+ T-cells express
the CD28 marker [14], but this is lost over time,
resulting in a low percentage of CD8+ ⁄CD28+ cells
in the elderly [15]. The loss of the CD28 marker is
accompanied by acquisition of distinct functional
activities [16,17]. CD8+ ⁄CD28– cells display the
characteristics of activated ⁄memory lymphocytes
with a greater cytotoxic ability [17,18]. Thus, a
large fraction of peripheral CD8+ T-cells from
children with DU (>60.0% are CD8+ ⁄CD28–)
display the phenotype of chronically activated
memory T-cells. In agreement with this observa-
tion, the number of CD8+ T-cells expressing the
HLA-DR activation marker increased by 200% in
children with the disease.
A decrease in CD8+ ⁄CD28+ cells and an
increase in CD8+ ⁄HLA-DR+ cells have also been
reported for cases of infection with human
immunodeﬁciency virus, and have been linked
to immune dysfunction and progression to AIDS
in both children [19] and adults [20]. The same
changes, although to a lesser degree, have been
observed in patients with active pulmonary
tuberculosis [20], and a similar pattern has been
demonstrated for the cardiac form of Chagas’
disease, in which a decreased frequency of
CD8+ ⁄CD28+ cells is observed in peripheral blood
[21] and activated CD8+ T-cells are found in the
inﬂammatory inﬁltrate of cardiac lesions [22]. In
the present study, since none of the patients had
T. cruzi infection, AIDS or tuberculosis, the chron-
ically activated cytotoxic CD8+ T-cells observed in
the group of children with DU seemed to be
associated with this severe clinical manifestation
of H. pylori infection in childhood.
Another difference observed in children with
DU was a decrease of 61.5% in the number of
CD19+ cells expressing CD5+. B-cells expressing
the CD5 marker on their surface (B1-cells) secrete
large amounts of natural antibodies in a T-cell-
independent manner, and are accepted as having
a clear role in the early defence mechanisms
against bacteria and viruses [23,24]. They have
also been regarded as part of a primitive mech-
anism that bridges innate and adaptive immunity
in certain specialised microenvironments, e.g., in
the gut mucosa [23,24]. Since it has been sug-
gested that B1-cell-derived natural IgA antibodies
have an important role in host defence mecha-
nisms against bacteria at the mucosa surface, the
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H. pylori load would be increased at the duodenal
mucosa of children with a low percentage of B1-
cells, with a consequent increased production of
enzymes, cytotoxins and other noxious bacterial
products that would predispose to ulcer forma-
tion. Given that the number of B-cells did not
differ signiﬁcantly between children with and
without DU, the shift from CD19+ ⁄CD5+ to
CD19+ ⁄CD5– cells observed in the former group
may be explained by a proportional increase in
the memory B-cells responsible for adaptive B
immunity. This may explain, at least in part, the
fact that serum levels of speciﬁc IgG against
H. pylori are higher in H. pylori-positive children
with DU than in those without DU [25].
As mentioned above, H. pylori infection leads to
CD4+ T-cell activation in adults [6], but patients
with DU have not been evaluated previously. In
the present study, a lower percentage of activated
CD4+ T-cells was observed in adults with DU
than in those without DU. These results, together
with those of Stro¨mberg et al. [26] that showed
low levels of pro-inﬂammatory cytokines in the
duodenal mucosa of adults with DU, suggest that
a down-regulated immune response occurs in
these patients, which may lead to a higher
bacterial load at the duodenal mucosa that would
predispose to ulceration.
The present results, showing a positive corre-
lation between the degree of gastritis and the
number of peripheral blood CD4+ T-cells in
children without DU, are similar to those of
Krauss-Etschmann et al. [27] and Lopes et al. [28],
who observed correlations between gastritis
scores and CD4+ T-cell numbers in the gastric
mucosa of infected children. These ﬁndings show
that peripheral blood, at least in part, mirrors the
gastric mucosa in terms of the immune response
to H. pylori. Thus, the positive correlations
observed between the number of mononuclear
cells in the gastric mucosa of adults without DU
and the number of peripheral blood CD4+ ⁄HLA-
DR+ and CD4+ ⁄CD28– cells suggests an increase in
the number of chronically activatedCD4+ T-cells in
the gastric mucosa of H. pylori-positive adults.
In interpreting the data of the present study, a
potential limitation that could be a source of bias
is the small number of children. The low preva-
lence of DU in childhood, ranging from four to six
new cases per year, or 1:2500 paediatric admis-
sions in large paediatric centres [29,30], including
this service [31], means that this problem is
difﬁcult to solve, but it was minimised as much
as possible by analysing the data with rank tests
for small samples.
Overall, the results of the present study dem-
onstrated that there are differences in the immu-
nophenotyping proﬁle between H. pylori-positive
children and adults with DU, suggesting distinct
immune mechanisms in the development of the
disease according to age.
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